# High Flow Nasal Cannula HFNC In Covid-19 Patients

> **NCT04560257** · NA · UNKNOWN · sponsor: **Lahore General Hospital** · enrollment: 30 (estimated)

## Conditions studied

- SARS-CoV Infection
- SARS (Severe Acute Respiratory Syndrome)

## Interventions

- **DEVICE:** High flow nasal cannula HFNC

## Key facts

- **NCT ID:** NCT04560257
- **Lead sponsor:** Lahore General Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-01
- **Primary completion:** 2020-12-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04560257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04560257, "High Flow Nasal Cannula HFNC In Covid-19 Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04560257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*